药物发现信息学市场增长、规模、份额、趋势、关键参与者分析及 2031 年预测

  • Report Code : TIPHE100000965
  • Category : Technology, Media and Telecommunications
  • No. of Pages : 150
Buy Now

 

[研究报告] 2023 年药物发现信息学市场价值为 30.7 亿美元,预计到 2031 年将达到 81.7 亿美元;预计 2023-2031 年期间的复合年增长率为 13.0%。

 

市场洞察和分析师观点:

药物发现信息学市场预测是基于各种二手和一手研究来源的发现得出的。

药物发现信息学是将计算和信息科学与化学和生物学相结合的领域。它使用各种计算工具、算法和数据库来研究和解释大量生物和化学数据。通过利用信息学的力量,研究人员可以加快药物发现过程,从而更高效、更经济地识别潜在的候选药物。因此,信息学工具的采用正在促进药物发现信息学市场规模的扩大。

 

影响药物发现信息学市场增长的驱动因素

制药和生物制药行业在研发方面投入巨资,以开发新产品并扩大免疫学、癌症和传染病等领域的产品线。例如,许多创新型制药公司现在正在投资基因组学,以重新激发药物发现的活力。根据《精准医学杂志》 2021 年 3 月发表的文章,阿斯利康启动了一个对 200 万个基因组进行测序的项目——这是一项大规模计划,旨在在未来十年收集基因组序列和健康记录。同一消息来源进一步指出,葛兰素史克投资 4000 万英镑(4248 万澳元)扩大与英国生物银行的合作。这项投资支持对 500,000 名个人进行测序,生成独特丰富的数据资源,既匿名又安全。领先的制药公司不是采购数据,而是利用富含基因组、表型和临床数据的人口数据集。因此,对专注于药物发现的活动的投资不断增加,正在推动药物发现信息学市场的增长。

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

药物发现信息学市场:

Drug Discovery Informatics Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

报告细分和范围:

“2031 年全球药物发现信息学市场分析”是一项专业而深入的研究,重点关注全球市场动态,以帮助确定关键驱动因素、未来趋势和有利可图的机会,进而有助于确定主要收入来源。该报告旨在提供市场概述,并按工作流程、服务、解决方案和最终用户对市场进行详细细分。药物发现信息学市场报告的范围包括北美(美国、加拿大和墨西哥)、欧洲(西班牙、英国、德国、法国、意大利和欧洲其他地区)、亚太地区(韩国、中国、印度、日本、澳大利亚和亚太其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。

 

节段分析:

根据工作流程,市场分为发现信息学和药物开发。发现信息学部分在 2023 年占据了更大的市场份额。药物开发部分预计在 2023 年至 2031 年期间将实现更高的复合年增长率。

按服务划分,市场分为序列分析平台、分子建模、临床试验数据管理、对接等。序列分析平台部分预计将在 2023 年占据药物发现信息学市场的最大份额。分子建模部分预计将在 2023 年至 2031 年期间实现最高复合年增长率。

根据解决方案,药物发现信息学市场分为软件和服务。服务部门在 2023 年占据了更大的市场份额,预计同一部门在 2023 年至 2031 年期间的复合年增长率将更高。

根据最终用户,市场分为制药和生物技术公司、合同研究组织和其他。制药和生物技术公司部门在 2023 年占据了最大的市场份额。合同研究组织部门预计将在 2023 年至 2031 年期间实现最高复合年增长率。

 

区域展望:

2023 年,北美占据了药物发现信息学市场的最大份额。美国在 2023 年占据了最大的市场份额,其次是加拿大。这归因于多种因素,例如 Charles River Laboratories、Certara 和 Curia 等主要参与者的存在、传染病的高发病率以及领先的制药公司和合同研究组织(CRO) 迅速采用新的和先进的研发工具进行药物发现和开发。这些公司越来越注重合资企业和研究合作,这有望进一步促进该地区的市场增长。例如,2022 年 8 月,Atomwise 与赛诺菲达成了一项战略性多目标研究合作,以进行人工智能驱动的药物发现。此次合作将专注于利用该公司的 AtomNet 平台对多达五个药物靶点进行计算发现和研究工作。

 

 

药物发现信息学市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响药物发现信息学市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的药物发现信息学市场细分和地理位置。

Drug Discovery Informatics Market
  • 获取药物发现信息学市场的区域特定数据

药物发现信息学市场报告范围

报告属性细节
2023 年的市场规模30.7亿美元
2031 年市场规模81.7亿美元
全球复合年增长率(2023 - 2031)13.0%
史料2021-2023
预测期2023-2031
涵盖的领域按工作流程
  • 发现信息学和药物开发
按服务
  • 序列分析平台
  • 分子建模
  • 临床试验数据管理
  • 对接
按解决方案
  • 软件和服务
按最终用户
  • 制药和生物技术公司
  • 合同研究组织
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 切塔拉
  • 印孚瑟斯公司
  • 合作药物研发公司
  • Jubliant Biosys
  • Curia Global, Inc.
  • 凯马克森有限公司
  • 查尔斯河实验室
  • 安捷伦科技公司
  • Illumina公司

 

药物发现信息学市场参与者密度:了解其对业务动态的影响

药物发现信息学市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在药物发现信息学市场运营的主要公司有:

  1. 切塔拉
  2. 印孚瑟斯公司
  3. 合作药物研发公司
  4. Jubliant Biosys
  5. Curia Global, Inc.

免责声明上面列出的公司没有按照任何特定顺序排列。


Drug Discovery Informatics Market

 

  • 获取药物发现信息学市场顶级关键参与者概述

 

行业发展和未来机遇:

根据公司新闻稿,全球药物发现信息学市场主要参与者采取的一些举措如下:

  • 2024 年 1 月,Evotec 与克罗恩病和结肠炎基金会合作开发炎症性肠病 (IBD) 的新疗法。根据这一合作关系,两家公司将利用 Evotec 的综合研发平台推进针对纤维化和肠道屏障功能受损的两个创新药物靶点的药物发现。
  • 2023 年 11 月,Certara 推出了 Simcyp Biopharmaceutics 软件,旨在提高新药和仿制药配方开发的效率。Simcyp Biopharmaceutics 软件旨在协助生物制药、配方和科学家快速且经济高效地配制复杂、新颖和仿制的小分子药物。
  • 2022 年 6 月,Chemical.AI 和 Chemaxon 宣布合作整合其科学信息学软件。知名人工智能 (AI) 公司 Chemical.AI 宣布与领先的化学和生物软件开发公司 Chemaxon 建立战略合作伙伴关系。此次合作允许最终用户选择访问 Chemaxon 的设计中心和 Chemical.AI 的 ChemAIRS。
  • 2022 年 4 月,Certara, Inc. 与 Chemaxon 达成战略合作伙伴关系,以实现药物研究的现代化。此次合作为双方的科学信息学工作流程提供了互联互通。Certara 的科学信息学软件将与 Chemaxon 的设计中心无缝连接,为用户提供分析和化合物设计。此次共同开发建立在 Certara 和 Chemaxon 产品(例如 JChem 化学墨盒、MarvinSketch 和 JChem for Office)之间的集成基础之上。

 

竞争格局和重点公司:

Certara;Infosys Ltd.;Collaborative Drug Discovery, Inc.;Jubliant Biosys;Curia Global, Inc.;Chemaxon Ltd;Charles River Laboratories、安捷伦科技公司、Illumina 公司、勃林格殷格翰国际有限公司和 Evotec 是药物发现信息学市场报告中介绍的知名公司。这些公司专注于新技术、现有产品改进和地域扩张,以满足全球日益增长的消费者需求。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is drug discovery informatics?

Drug discovery informatics is a field that integrates computational and information sciences with chemistry and biology. It uses various computational tools, algorithms, and databases to study and interpret vast volumes of biological and chemical data.

Who are the major players in the drug discovery informatics?

The drug discovery informatics majorly consists of the players, including Certara; Infosys Ltd.; Collaborative Drug Discovery, Inc.; Jubliant Biosys; Curia Global, Inc.; Chemaxon Ltd; Charles River Laboratories; Agilent Technologies, Inc.; Illumina, Inc; Boehringer Ingelheim International GmbH; and Evotec.

What factors drive the drug discovery informatics?

Key factors driving the drug discovery informatics growth are the increasing investments in the R&D of new drug molecules by pharmaceutical companies and the growing adoption of computational and information tools for drug discovery and development.

Which type segment dominates the drug discovery informatics?

The drug discovery informatics market, by workflow, is bifurcated into discovery informatics and drug development. The discovery informatics segment held a larger market share in 2023.

What was the estimated drug discovery informatics size in 2023?

The drug discovery informatics was valued at US$ 3.073billion in 2023.

What are the growth estimates for the drug discovery informatics till 2031?

The drug discovery informatics is expected to be valued at US$ 8.17 billion in 2031.

Trends and growth analysis reports related to Technology, Media and Telecommunications : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Drug Discovery Informatics Market

  1. Certara
  2.  Infosys Ltd.
  3.  Collaborative Drug Discovery, Inc.
  4.  Jubliant Biosys
  5. Curia Global, Inc.
  6. Chemaxon Ltd
  7. Charles River Laboratories
  8. Agilent Technologies, Inc.
  9. Illumina, Inc
  10. Boehringer Ingelheim International GmbH

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.